Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BLOCK LISTING SIX MONTHLY RETURN

15 Sep 2017 14:00

RNS Number : 9199Q
Dechra Pharmaceuticals PLC
15 September 2017
 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Long-Term Incentive Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

21,507

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

174,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

195,507

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Approved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

8,184

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

25,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

6,077

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

27,107

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

Unapproved Share Option Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

65,972

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

55,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

23,254

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

97,718

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

BLOCK LISTING SIX MONTHLY RETURN

 

Information provided on this form must be typed or printed electronically and provided to an ris.

 

Date: 15 September 2017

 

Name of applicant:

Dechra Pharmaceuticals PLC

Name of scheme:

SAYE Scheme

Period of return:

From:

15 March 2017

To:

14 September 2017

Balance of unallotted securities under scheme(s) from previous return:

11,811

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

75,000

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

70,378

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

16,433

 

 

 

Name of contact:

Melanie Hall

Telephone number of contact:

01606 814 730

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGUQABUPMGPA
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.